# CHSY1

## Overview
The CHSY1 gene encodes the enzyme chondroitin sulfate synthase 1, which is integral to the biosynthesis of chondroitin sulfate, a vital component of the extracellular matrix. This enzyme is categorized as a glycosyltransferase, responsible for the elongation of chondroitin sulfate chains by adding alternating glucuronic acid and N-acetylgalactosamine residues. The protein's activity is crucial for maintaining the structural integrity of tissues and modulating key signaling pathways, such as NOTCH and Indian hedgehog, which are essential for normal cellular functions and developmental processes (Wilson2012Chondroitin; Tian2010Loss). Mutations in the CHSY1 gene are linked to Temtamy preaxial brachydactyly syndrome, highlighting its significance in skeletal development and joint formation (Li2010Temtamy). Additionally, CHSY1's interactions with other proteins underscore its role in both physiological and pathological contexts, including cancer progression (Liu2017CHSY1; Liao2020Chondroitin).

## Structure
CHSY1 (chondroitin sulfate synthase 1) is an enzyme that plays a crucial role in the biosynthesis of chondroitin sulfate, a key component of the extracellular matrix. The primary structure of CHSY1 is composed of a sequence of amino acids encoded by the CHSY1 gene. This sequence determines the protein's specific functions and interactions within the cell.

The secondary structure of CHSY1 includes alpha helices and beta sheets, which contribute to the protein's stability and functional conformation. These structural elements are essential for the proper folding and function of the enzyme.

In terms of tertiary structure, CHSY1 exhibits a three-dimensional folding pattern that may include specific domains such as glycosyltransferase domains. These domains are critical for the enzyme's activity in transferring glycosyl groups during the synthesis of chondroitin sulfate.

The quaternary structure of CHSY1, if applicable, would involve the assembly of multiple subunits, although specific details on this aspect are not provided in the context.

Post-translational modifications, such as glycosylation, can influence the function of CHSY1, potentially affecting its enzymatic activity and interactions with other molecules. Additionally, splice variant isoforms of CHSY1 may exist, which could alter the protein's structure and function, providing a mechanism for regulating its activity in different cellular contexts.

## Function
The CHSY1 gene encodes chondroitin sulfate synthase 1, an enzyme crucial for the biosynthesis of chondroitin sulfate (CS), a type of glycosaminoglycan. This enzyme is involved in the elongation of CS chains by catalyzing the addition of alternating glucuronic acid and N-acetylgalactosamine residues, which are essential components of the extracellular matrix proteoglycans (Wilson2012Chondroitin; Izumikawa2013A). CHSY1 possesses both glucuronyltransferase II and N-acetylgalactosaminyl-transferase II activities, necessary for synthesizing the repeating disaccharide units of CS (Tian2010Loss).

In healthy human cells, CHSY1 is secreted and accumulates in the extracellular space, where it plays a pivotal role in maintaining the structural integrity and function of various tissues (Tian2010Loss). The enzyme is involved in modulating interactions with NOTCH receptors, thereby influencing NOTCH signaling pathways, which are important for normal cellular functions and developmental processes (Tian2010Loss). CHSY1 also affects the distribution and signaling of Indian hedgehog (Ihh), a key regulator of chondrocyte differentiation and skeletal growth, by ensuring proper sulfation of chondroitin sulfate proteoglycans (Wilson2012Chondroitin). The enzyme's activity is crucial for bone development, digit patterning, and the regulation of joint patterning (Wilson2012Chondroitin).

## Clinical Significance
Mutations in the CHSY1 gene are associated with Temtamy preaxial brachydactyly syndrome (TPBS), a rare autosomal recessive disorder. TPBS is characterized by limb malformations, such as preaxial brachydactyly and hyperphalangism, as well as facial dysmorphism, dental anomalies, sensorineural hearing loss, and growth retardation (Li2010Temtamy; Sher2014A). The CHSY1 gene encodes chondroitin synthase 1, which is crucial for the biosynthesis of chondroitin sulfate, a glycosaminoglycan important for bone growth and joint formation (Sher2014A).

Loss-of-function mutations in CHSY1 disrupt its role in chondroitin sulfate synthesis, leading to the clinical manifestations of TPBS (Li2010Temtamy). These mutations can result in nonfunctional CHSY1 protein, affecting bone morphogenetic protein (BMP) signaling pathways, which are essential for proper skeletal development (Li2010Temtamy). Studies in zebrafish and mice have shown that both loss and gain of CHSY1 function can lead to developmental defects similar to those observed in human TPBS patients, indicating its critical role in skeletal and cartilage development (Wilson2012Chondroitin; Li2010Temtamy).

Additionally, CHSY1 mutations have been linked to peripheral neuropathies, as they impair the elongation of chondroitin sulfate chains, which are important for various biological functions (Izumikawa2013A). These findings underscore the clinical significance of CHSY1 in human developmental disorders and its potential impact on cartilage and bone health.

## Interactions
CHSY1 (chondroitin sulfate synthase 1) is involved in several protein interactions crucial for its role in chondroitin sulfate biosynthesis. It interacts with chondroitin sulfate synthase-3 (CSS3, also known as ChSy-2) and chondroitin-polymerizing factor (ChPF), forming complexes that enhance its glycosyltransferase and polymerase activities. These interactions are essential for effective chondroitin polymerization, as demonstrated by pull-down assays showing that ChSy-1 interacts with both CSS3 and ChPF (Izumikawa2007Involvement).

In the context of cancer, CHSY1 has been implicated in modulating the stability of PDGFRA (platelet-derived growth factor receptor alpha) in glioblastoma. This interaction enhances PDGFRA signaling, which is crucial for glioma development and progression (Liao2020Chondroitin). CHSY1 is also involved in the hedgehog signaling pathway in hepatocellular carcinoma, where it enhances Sonic Hedgehog (SHH) binding to the cell surface, promoting aggressive cancer phenotypes (Liu2017CHSY1).

These interactions highlight CHSY1's role in both normal physiological processes and pathological conditions, particularly in cancer progression.


## References


[1. (Liao2020Chondroitin) Wen-Chieh Liao, Chih-Kai Liao, To-Jung Tseng, Ying-Jui Ho, Ying-Ru Chen, Kuan-Hung Lin, Te-Jen Lai, Chyn-Tair Lan, Kuo-Chen Wei, and Chiung-Hui Liu. Chondroitin sulfate synthase 1 enhances proliferation of glioblastoma by modulating pdgfra stability. Oncogenesis, February 2020. URL: http://dx.doi.org/10.1038/s41389-020-0197-0, doi:10.1038/s41389-020-0197-0. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41389-020-0197-0)

[2. (Liu2017CHSY1) Chiung-Hui Liu, Chyn-Tair Lan, Jui-Feng Chou, To-Jung Tseng, and Wen-Chieh Liao. Chsy1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway. Cancer Letters, 403:280–288, September 2017. URL: http://dx.doi.org/10.1016/j.canlet.2017.06.023, doi:10.1016/j.canlet.2017.06.023. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2017.06.023)

[3. (Wilson2012Chondroitin) Deanna G. Wilson, Khanhky Phamluong, Wei Yu Lin, Kai Barck, Richard A.D. Carano, Lauri Diehl, Andrew S. Peterson, Flavius Martin, and Mark J. Solloway. Chondroitin sulfate synthase 1 (chsy1) is required for bone development and digit patterning. Developmental Biology, 363(2):413–425, March 2012. URL: http://dx.doi.org/10.1016/j.ydbio.2012.01.005, doi:10.1016/j.ydbio.2012.01.005. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ydbio.2012.01.005)

[4. (Izumikawa2007Involvement) Tomomi Izumikawa, Toru Uyama, Yuka Okuura, Kazuyuki Sugahara, and Hiroshi Kitagawa. Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor. Biochemical Journal, 403(3):545–552, April 2007. URL: http://dx.doi.org/10.1042/bj20061876, doi:10.1042/bj20061876. This article has 88 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20061876)

[5. (Sher2014A) Gulab Sher and Muhammad Naeem. A novel chsy1 gene mutation underlies temtamy preaxial brachydactyly syndrome in a pakistani family. European Journal of Medical Genetics, 57(1):21–24, January 2014. URL: http://dx.doi.org/10.1016/j.ejmg.2013.11.001, doi:10.1016/j.ejmg.2013.11.001. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejmg.2013.11.001)

[6. (Izumikawa2013A) Tomomi Izumikawa, Kazumasa Saigoh, Jun Shimizu, Shoji Tsuji, Susumu Kusunoki, and Hiroshi Kitagawa. A chondroitin synthase-1 (chsy-1) missense mutation in a patient with neuropathy impairs the elongation of chondroitin sulfate chains initiated by chondroitin n-acetylgalactosaminyltransferase-1. Biochimica et Biophysica Acta (BBA) - General Subjects, 1830(10):4806–4812, October 2013. URL: http://dx.doi.org/10.1016/j.bbagen.2013.06.017, doi:10.1016/j.bbagen.2013.06.017. This article has 13 citations.](https://doi.org/10.1016/j.bbagen.2013.06.017)

[7. (Tian2010Loss) Jing Tian, Ling Ling, Mohammad Shboul, Hane Lee, Brian O’Connor, Barry Merriman, Stanley F. Nelson, Simon Cool, Osama H. Ababneh, Azmy Al-Hadidy, Amira Masri, Hanan Hamamy, and Bruno Reversade. Loss of chsy1, a secreted fringe enzyme, causes syndromic brachydactyly in humans via increased notch signaling. The American Journal of Human Genetics, 87(6):768–778, December 2010. URL: http://dx.doi.org/10.1016/j.ajhg.2010.11.005, doi:10.1016/j.ajhg.2010.11.005. This article has 75 citations.](https://doi.org/10.1016/j.ajhg.2010.11.005)

[8. (Li2010Temtamy) Yun Li, Kathrin Laue, Samia Temtamy, Mona Aglan, L. Damla Kotan, Gökhan Yigit, Husniye Canan, Barbara Pawlik, Gudrun Nürnberg, Emma L. Wakeling, Oliver W. Quarrell, Ingelore Baessmann, Matthew B. Lanktree, Mustafa Yilmaz, Robert A. Hegele, Khalda Amr, Klaus W. May, Peter Nürnberg, A. Kemal Topaloglu, Matthias Hammerschmidt, and Bernd Wollnik. Temtamy preaxial brachydactyly syndrome is caused by loss-of-function mutations in chondroitin synthase 1, a potential target of bmp signaling. The American Journal of Human Genetics, 87(6):757–767, December 2010. URL: http://dx.doi.org/10.1016/j.ajhg.2010.10.003, doi:10.1016/j.ajhg.2010.10.003. This article has 76 citations.](https://doi.org/10.1016/j.ajhg.2010.10.003)